Cargando…
Lectin‐based phototherapy targeting cell surface glycans for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is resistant to current treatments but lectin‐based therapy targeting cell surface glycans could be a promising new horizon. Here, we report a novel lectin‐based phototherapy (Lec‐PT) that combines the PDAC targeting ability of rBC2LCN lectin to a photoabsorbe...
Autores principales: | Kuroda, Yukihito, Oda, Tatsuya, Shimomura, Osamu, Hashimoto, Shinji, Akashi, Yoshimasa, Miyazaki, Yoshihiro, Furuya, Kinji, Furuta, Tomoaki, Nakahashi, Hiromitsu, Louphrasitthiphol, Pakavarin, Mathis, Bryan J, Nakajima, Takahito, Tateno, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107464/ https://www.ncbi.nlm.nih.gov/pubmed/36412556 http://dx.doi.org/10.1002/ijc.34362 |
Ejemplares similares
-
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer:
(18)F‐labeled rBC2LCN lectin
por: Kuroda, Yukihito, et al.
Publicado: (2023) -
Lectin drug conjugate therapy for colorectal cancer
por: Kitaguchi, Daichi, et al.
Publicado: (2020) -
Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells
por: Furuta, Tomoaki, et al.
Publicado: (2021) -
Glycan and lectin biosensors
por: Belický, Štefan, et al.
Publicado: (2016) -
Prospective Randomized Controlled Pilot Study of High-Intensity Lightbox Phototherapy to Prevent ICU-Acquired Delirium Incidence
por: Zhang, Kermit S, et al.
Publicado: (2021)